Merger Notification - Announcement according to § 10 Cartel Act
Apollo Management, L.P., USA; Covis Pharma GmbH; AstraZeneca UK Limited
BWB/Z-5763
On 16.11.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Covis Pharma GmbH, Switzerland, a company indirectly controlled by investment funds managed by affiliates of Apollo Management, L.P., USA, intends to acquire the global commercialization rights and all related assets of products to treat chronic obstructive pulmonary disease (COPD) from AstraZeneca UK Limited, UK."
Economic Sector: Wholesale of pharmaceutical products
Industry sector: G - Handel; Instandhaltung und Reparatur von Kraftfahrzeugen
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 14.12.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 15.12.2021 .